CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$1.59 USD
-0.01 (-0.63%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.59 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: -- |
3/2024 | $-0.04 | -175.00% |
Earnings Summary
For their last quarter, CytomX Therapeutics (CTMX) reported earnings of $0.01 per share, missing the Zacks Consensus Estimate of $0.02 per share. This reflects a negative earnings surprise of 50.00%. Look out for CTMX's next earnings release expected on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.04 per share, reflecting a year-over-year increase of 20%.
Earnings History
Price & Consensus
Zacks News for CTMX
GSK Gears Up for Q1 Earnings: Here's What to Expect
CTMX: What are Zacks experts saying now?
Zacks Private Portfolio Services